| # | Drug | Count |
|---|---|---|
| 0 | INSULIN GLARGINE | 70 |
| 1 | INSULIN LISPRO | 61 |
| 2 | HUMAN INSULIN | 50 |
| 3 | INSULIN GLULISINE | 20 |
| 4 | INSULIN HUMAN | 20 |
| 5 | INSULIN GLARGINE-YFGN | 19 |
| 6 | INSULIN ASPART | 17 |
| 7 | FUROSEMIDE | 13 |
| 8 | PIOGLITAZONE | 12 |
| 9 | ASPIRIN | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HUMAN INSULIN | 50 | 0.0070 |
| 1 | LULICONAZOLE | 1 | 0.0057 |
| 2 | MIGLITOL | 5 | 0.0052 |
| 3 | NATEGLINIDE | 3 | 0.0022 |
| 4 | INSULIN GLULISINE | 20 | 0.0020 |
| 5 | INSULIN GLARGINE-YFGN | 19 | 0.0008 |
| 6 | SITAGLIPTIN PHOSPHATE | 2 | 0.0007 |
| 7 | NIZATIDINE | 1 | 0.0007 |
| 8 | SODIUM POLYSTYRENE SULFONATE | 1 | 0.0006 |
| 9 | ACARBOSE | 2 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | alpha-Glucosidase Inhibitor [EPC] | 7 | 0.0014 |
| 1 | Insulin [EPC] | 66 | 0.0014 |
| 2 | Glinide [EPC] | 3 | 0.0003 |
| 3 | Insulin Analog [EPC] | 119 | 0.0003 |
| 4 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 5 | Potassium Binder [EPC] | 1 | 0.0001 |
| 6 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 2 | 0.0001 |
| 7 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 3 | 0.0001 |
| 8 | CTLA-4-directed Blocking Antibody [EPC] | 2 | 0.0000 |
| 9 | alpha-Adrenergic Blocker [EPC] | 5 | 0.0000 |